RETATRUTIDE 40mg: Research only

Retatrutide is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, studied for its powerful weight reduction and metabolic improvement potential.

Manufactured under stringent quality control standards to ensure consistency and integrity in research applications.

Notice:
This product is intended strictly for research purposes. It is not for human consumption or use in diagnostic, therapeutic, or clinical procedures.